Yvonne Grobben
Oss, NB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Combined cellular and biochemical profiling of Bruton's tyrosine kinase inhibitor nemtabrutinib reveals potential application in MAPK-driven cancers.
Journal: Frontiers in oncology
Published: July 16, 2025
Synthesis and Absolute Configuration of the Sesquiterpene Lactone EPD, a Natural Product with Broad Antitumor Cell Activity via a Unique Mechanism of Action.
Journal: Journal of natural products
Published: July 04, 2025
Targeting amino acid-metabolizing enzymes for cancer immunotherapy.
Journal: Frontiers in immunology
Published: May 29, 2024
Amino Acid-Metabolizing Enzymes in Advanced High-Grade Serous Ovarian Cancer Patients: Value of Ascites as Biomarker Source and Role for IL4I1 and IDO1.
Journal: Cancers
Published: November 03, 2022
Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0.
Journal: Frontiers in immunology
Published: September 23, 2020
Pharmacological validation of TDO as a target for Parkinson's disease.
Journal: The FEBS journal
Published: September 11, 2020
High-Throughput Fluorescence-Based Activity Assay for Arginase-1.
Journal: SLAS discovery : advancing life sciences R & D
Published: May 19, 2020
Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascites.
Journal: Oncotarget
Published: April 08, 2020
Structural insights into human Arginase-1 pH dependence and its inhibition by the small molecule inhibitor CB-1158.
Journal: Journal of structural biology: X
Published: October 19, 2019
Installation of Trimethyllysine Analogs on Intact Histones via Cysteine Alkylation.
Journal: Bioconjugate chemistry
Published: February 23, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026